Menu
PPD Blog
PPD Blog

Sharing industry knowledge as we
help deliver life-changing therapies.

 

Cancer patient with medical professional for the challenges of combination therapies in immuno-oncology clinical development

The challenges of immuno-oncology clinical development, Part II

In the second of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.

Read more...
 

Challenges of immuno-oncology clinical development

The challenges of immuno-oncology clinical development, Part I

In the first of a four-part series, Jai Balkissoon, vice president of global product development, writes about the increase in immuno-oncology therapies.

Read more...
 

Local regulatory affiliates

The future of the local regulatory affiliate: Adjusting to global strategies, processes and expectations

Alistair Davidson, senior director, regulatory affairs, discusses the work of local regulatory affiliates.

Read more...
 

Lungs tuberculosis drug development

PPD’s fight against tuberculosis: Clinical trials with experienced teams

As we recognize World TB (tuberculosis) Day, PPD employees share their experiences working against the disease and their dedication to seek life-changing therapies for TB patients.

Read more...
 

Rare disease day 2018

The personal impact of rare diseases

PPD employees, including a rare disease patient, parent and researcher, share their experiences as we honor Rare Disease Day.

Read more...
 

Benefits of centralized monitoring in clinical trials

Benefits of centralized monitoring in clinical trials

Nicole Stansbury, executive director of adaptive and intelligent monitoring, answers questions about PPD’s clinical trial monitoring strategies.

Read more...
 

Infrastructure Design Is Key to Enhanced Clinical Trials Data Management thumbnail image

Infrastructure design is key to enhanced clinical trials data management

Brent Reed, director of information technology, writes about elements required for managing data for a successful clinical trial.

Read more...
 

Proactivity in a GMP Contract Laboratory thumbnail

Proactivity in a GMP contract laboratory

Chris Forsdyke, executive director, PPD® Laboratories’ GMP lab in Athlone, Ireland, details why proactivity is important even in a regulated laboratory environment.

Read more...
 

Positive changes in the Latin American clinical trial regulatory environment

Positive changes in the Latin American clinical trial regulatory environment

Andres Bayona, executive director in clinical monitoring and regional head of Latin America, and Mercedes Ponce de Leon, senior manager in regulatory affairs, discuss the clinical trial regulatory landscape in Latin America.

Read more...
 

Why use liquid chromatography-mass spectrometry in drug discovery and development?

Why use liquid chromatography-mass spectrometry in drug discovery and development?

Jie Ding, associate director of development and validation at the PPD® Laboratories’ GMP lab, discusses liquid chromatography-mass spectrometry in drug discovery and development.

Read more...
 

First-in-health regulatory changes Kirsten Messmer

Seeking ways to ensure participant safety in first-in-human trials

Kirsten Messmer, Ph.D., R.A.C., principal regulatory affairs specialist, details changes in regulatory guidelines for first-in-human trials.

Read more...
 

Honoring World Alzheimer’s Day Neuroscience Research

Honoring World Alzheimer's Day

Stephen Peroutka, vice president and therapeutic area head in neuroscience, shares his thoughts on the importance and outlook of conducting clinical trials for Alzheimer’s disease.

Read more...
 

Brexit’s potential regulatory impact on the pharmaceutical industry

Brexit's potential regulatory impact on the pharmaceutical industry

Regulatory affairs experts at PPD, Alistair Davidson and Vincenzo Cannizzaro, reflect on how the United Kingdom's departure from the European Union might impact the pharmaceutical industry.

Read more...
 

Major clinical trial reforms underway in China’s regulatory environment thumbnail image

Major clinical trial reforms underway in China's regulatory environment

Bill Wang, director of regulatory affairs, discusses China's regulatory environment in the second-largest pharmaceutical market in the world.

Read more...
 

Pediatric research: Overcoming challenges and building community thumbnail image

Pediatric research: Overcoming challenges and building community

Horacio Plotkin, vice president and medical lead, Rare Disease and Pediatric Center of Excellence, discusses the challenges researchers face when conducting studies in the pediatric space and talks about the impact of PPD’s Pediatric Investigator Network (PIN), a network of 14 pediatric centers of excellence established to share scientific thinking, improve pediatric study design and communicate knowledge across the international research community.

Read more...
Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.